欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0695/001
药品名称Progesterone
活性成分
    • progesterone 400.0 mg
剂型Pessary
上市许可持有人L.D. Collins & Co Ltd, 1st Floor Gallery Court, 28 Arcadia Avenue, London N3 2FG, United Kingdom
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Netherlands (NL)
      Cyclogest
    • Luxembourg (LU)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
      Cyclogest
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      Cyclogest 400 mg Vaginalzäpfchen
    • Denmark (DK)
    • Belgium (BE)
      Amelgen 400 mg ovulen, ovules, Vaginalzäpfchen
    • Poland (PL)
      Cyclogest
    • Iceland (IS)
      Cyclogest 400 mg skeiðarstíll
    • Austria (AT)
      Cyclogest 400 mg Scheidenpessar
    • France (FR)
    • Romania (RO)
      Cyclovita 400 mg ovule
    • Italy (IT)
    • Greece (GR)
      CYCLOGEST
    • Slovakia (SK)
      Amelgen
    • Finland (FI)
    • Latvia (LV)
      Amelgen 400 mg pesāriji
    • Estonia (EE)
      AMELGEN
    • Hungary (HU)
      CYCLOGEST 400 mg hüvelykúp
    • Bulgaria (BG)
      Cyclogest
    • Slovenia (SI)
    • Cyprus (CY)
      CYCLOGEST
    • Czechia (CZ)
      Amelgen 400 mg vaginální kuličky
    • Malta (MT)
      Cyclogest 400mg Pessaries
    • Croatia (HR)
      Cyclogest 400 mg vagitoriji
许可日期2017/01/06
最近更新日期2023/12/04
药物ATC编码
    • G03DA04 progesterone
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase